Live Breaking News & Updates on Yutaka Niihara

Stay updated with breaking news from Yutaka niihara. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Doctors Daar, Niihara honored by The Lundquist Institute

By Elka Worner When two Lundquist Institute doctors began their research into HIV and sickle cell disease, getting an HIV diagnosis was a death sentence and… ....

United States , Yutaka Niihara , Juanita Gougis , Albert Schweitzer , Eric Daar , Sickle Cell Foundation , Lundquist Institute Max Benavidez , Lundquist Institute , South Central , Middle East ,

Emmaus Life Sciences Reports Management Changes

Emmaus Life Sciences, Inc. (OTCQX: EMMA), a commercial-stage biopharmaceutical company and leader in the treatment of sickle cell disease, today reported that on August 18, 2023 the Board of Directors, including Yutaka Niihara, M.D., Ph.D, determined that Dr. Niihara would no longer serve as Chief Executive Officer of Emmaus, or as Chairman of the Board, in order to allow Dr. Niihara to pursue business opportunities in Ube, Japan and in India previously initiated by Emmaus. Dr. Niihara was the p ....

United States , United Arab Emirates , Saudi Arabia , Kingdom Of Saudi Arabia , George Sekulich , Willis Lee , Exchange Commission On , Saudi Food Drug Authority , Committee On Addressing Sickle Cell Disease , Emmaus Life Sciences , Centers For Disease , Emmaus Life Sciences Inc , Blueprint For Action National Academy Of Sciences , National Center On Birth Defects , Company Contact , Drug Administration , Chief Operating Officer , Chief Information Officer , Senior Vice President Global Commercialization , Chief Executive , Middle East North Africa , Life Sciences , Saudi Food , Prescribing Information , Sickle Cell Disease , National Center ,

Emmaus Life Sciences aims to boost sales of sickle cell treatment amid leadership change

Emmaus Life Sciences Inc (OTCQX:EMMA) said Dr. Yutaka Niihara will no longer serve as the company’s CEO as Dr. Niihara pursues business opportunities in. ....

Willis Lee , Yutaka Niihara , George Sekulich , Drug Administration , Emmaus Life Sciences Inc , Middle East North Africa ,

Emmaus Life Sciences : Reports Q2 2023 Financial Results

Emmaus Life Sciences Reports Q2 2023 Financial Results

Record Net Revenues Contributed to Income from Operations

Sixth Straight Quarterly Increase in Net.
-Today at 03:28 pm- MarketScreener ....

United Arab Emirates , United States , Saudi Arabia , Kingdom Of Saudi Arabia , Willis Lee , Yutaka Niihara , National Center On Birth Defects , Centers For Disease , Emmaus Life Sciences Inc , Emmaus Life Sciences Reports , Emmaus Life Sciences , Saudi Food Drug Authority , Company Contact , Exchange Commission On , Committee On Addressing Sickle Cell Disease , Blueprint For Action National Academy Of Sciences , Drug Administration , Net Revenues Contributed , Straight Quarterly Increase , Life Sciences , Middle East North Africa , Chief Executive Officer , Saudi Food , Prescribing Information , Sickle Cell Disease , Birth Defects ,

Emmaus Life Sciences Reports Q2 2023 Financial Results

/PRNewswire/ Emmaus Life Sciences, Inc. (OTCQX: EMMA), a commercial-stage biopharmaceutical company and leader in the treatment of sickle cell disease,. ....

Saudi Arabia , United States , United Arab Emirates , Kingdom Of Saudi Arabia , Willis Lee , Yutaka Niihara , Drug Administration , Exchange Commission On , Prnewswire Emmaus Life Sciences Inc , National Center On Birth Defects , Centers For Disease , Emmaus Life Sciences Inc , Committee On Addressing Sickle Cell Disease , Blueprint For Action National Academy Of Sciences , Emmaus Life Sciences , Company Contact , Saudi Food Drug Authority , Record Net Revenues Contributed , Straight Quarterly Increase , Life Sciences , Middle East North Africa , Chief Executive Officer , Saudi Food , Prescribing Information , Sickle Cell Disease , National Center ,